Projects funded by the NCN


Information on the principal investigator and host institution

Information of the project and the call

Keywords

Equipment

Delete all

Search results

6 projects found matching your search criteria :

  1. Personalized selective activation of γδT Vδ2 cells using zoledronic acid for glioblastoma MICA/Bhigh therapy: in vitro a...

    Call: PRELUDIUM 24 , Panel: NZ4

    Principal investigator: Natalia Anna Lehman

    Uniwersytet Medyczny w Lublinie

  2. Elimination of IgE-producing cells using next-generation chimeric antigen receptor (CAR)-based therapy

    Call: OPUS 29 , Panel: NZ6

    Principal investigator: dr hab. Beata Kaleta

    Warszawski Uniwersytet Medyczny

  3. New approach to glioblastoma adoptive therapy based on inducible CAR expression system - SynCAR

    Call: OPUS 29 , Panel: NZ6

    Principal investigator: dr hab. Radosław Zagożdżon

    Warszawski Uniwersytet Medyczny

  4. Increasing the precision of chimeric antigen receptor (CAR)-mediated anticancer immunotherapy by using the chemokine-ind...

    Call: OPUS 19 , Panel: NZ6

    Principal investigator: dr hab. Radosław Zagożdżon

    Warszawski Uniwersytet Medyczny

  5. The role of the oxidative stress in adoptive cell therapy with chimeric antigen receptors

    Call: OPUS 17 , Panel: NZ6

    Principal investigator: dr Małgorzata Agnieszka Bajor

    Instytut Medycyny Doświadczalnej i Klinicznej im. Mirosława Mossakowskiego PAN

  6. Evaluation of the anticancer efficacy of a new chimeric antigen receptor targeting PD-L1 molecule

    Call: OPUS 12 , Panel: NZ6

    Principal investigator: dr hab. Radosław Zagożdżon

    Warszawski Uniwersytet Medyczny, Wydział Lekarski